Penserra Capital Management’s Aevi Genomic Medicine, Inc. GNMX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2017
Q2 | – | Sell |
-8,267
| Closed | -$15K | – | 607 |
|
|
2017
Q1 | $15K | Buy |
8,267
+3,543
| +75% | +$6.43K | ﹤0.01% | 416 |
|
|
2016
Q4 | $24K | Buy |
4,724
+460
| +11% | +$2.34K | ﹤0.01% | 536 |
|
|
2016
Q3 | $23K | Buy |
4,264
+1,066
| +33% | +$5.75K | ﹤0.01% | 472 |
|
|
2016
Q2 | $18K | Sell |
3,198
-346
| -10% | -$1.95K | ﹤0.01% | 483 |
|
|
2016
Q1 | $15 | Buy |
3,544
+1,181
| +50% | +$5 | ﹤0.01% | 480 |
|
|
2015
Q4 | $14K | Buy |
+2,363
| New | +$14K | ﹤0.01% | 472 |
|